跳至主要内容
临床试验/NCT06438523
NCT06438523招募中不适用

A-prf,Nanochitosan Combined With A-prf Scaffold Compared to Chitosan in Vital Pulp Therapy for Symptomatic Irreversible Pulpitis of Mature Permanent Mandibular First Molar Teeth .Randomized Controlled Trials

Future University in Egypt1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2023年9月2日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
30
试验地点
1
主要终点
pain assessment

研究概览

简要总结

Clinical and radiographic assessment of A-prf,A-prf combined with nanochitosan compared to chitosan for symptomatic irreversible pulpits in lower permanent first molar

详细描述

3 groups are allocated using : Aprf Aprf combined with nanochitosan Chitosan

Each group will be subjected to tests:

Tooth sensibility via EPT (electrical pulp tester)and thermal test Radiolucency in digital radiograph Pain in NRS(6-12-24-72h)for 1 week

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
15 Years 至 30 Years(Child, Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Patients suffering from Symptomatic irreversible pulpitis in mature mandibular molars only will be involved.
  • •Patients of either gender aged from 15-
  • •Tooth should give positive response to cold test.
  • •Haemostasias should be achieved after total pulpotomy.
  • •The tooth is restorable and free from advanced periodontal disease, cracks and splits.
  • •Patients should be free from any systemic disease that may affect normal healing and predictable outcome.
  • •Patients who will agree to the consent and will commit to follow-up period.
  • •Patients with mature root.
  • •Patients with no internal or external resorption and no periapical lesions.
  • •Soft tissues around the tooth are normal with no swelling or sinus tract.

排除标准

  • •Patients with immature roots.
  • •Haemostasias after 10 minutes can not be controlled after total pulpotomy
  • •Patients with any systemic disease that may affect normal healing.
  • •Patients with periapical lesions or infections.
  • •Pregnant females.
  • •Patients who could/would not participate in a 6 months follow-up.
  • •Patients with fistula or swelling
  • •Patients with necrotic pulp.
  • •Patients with old age.

研究组 & 干预措施

Advanced Platelet rich fibrin,A-prf,A-PRF scaffold

Experimental

A-PRF will be prepared according to Choukroun's technique by drawing whole blood from the median cubital vein into a 10 ml plain plastic test tubes (non-citrated) without the addition of an anticoagulant reagent .

To prevent the blood from coagulating, it will be centrifuged immediately using a table top centrifuge at 1500 rpm for 14 minute.

干预措施: PULPOTOMY OF MATURE PERMENANT TEETH (Procedure)

A-prf mixed with nano chitosan

Experimental

A-PRF will be prepared according to Choukroun's technique by drawing whole blood from the median cubital vein into a 10 ml plain plastic test tubes (non-citrated) without the addition of an anticoagulant reagent .

To prevent the blood from coagulating, it will be centrifuged immediately using a table top centrifuge at 1500 rpm for 14 minute then mixed with nanochitosan

干预措施: PULPOTOMY OF MATURE PERMENANT TEETH (Procedure)

chitosan

Experimental

he access cavity will be prepared up to the level of pulp chamber floor using sterile round diamond bur size 1 in high-speed hand piece with coolant.Once the pulp has been reached, a sharp sterile excavator should be used to remove the pulp tissue to the level of the radicular/root canal orifices then chitosan will be applied

干预措施: PULPOTOMY OF MATURE PERMENANT TEETH (Procedure)

结局指标

主要结局

pain assessment

时间窗: 6,12,24,72hours and 7 days postoperative

Pain assessment using numerical rate scale

次要结局

  • Clinical and radiographic success(1,3,6,9and 12 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mai Sherif

Researcher

Future University in Egypt

研究点 (1)

Loading locations...

相似试验